Randomization: Retatrutide vs placebo
Women should discontinue tirzepatide at least one month before planned conception and seek immediate medical advice if pregnancy occurs during treatment
It offers particular benefits for patients with weight-related conditions like type 2 diabetes, hypertension, or high cholesterol
Authors contributions Conception of the consensus statement: ADO, LJO, JIMA, BJS, DLH Data extraction: LJO, AS, JMIA, KDK, ES, CRFR, RC Interpretation of data: ADO, LJO, BJS, AS, JMIA, KDK, ES, CRFR, RC, MDHA, CEM, MC, RM, GEU, DLH Writing the manuscript: ADO, LJO, AS, JMIA, MDHA, KDK, ES, CRFR, RC Revising the manuscript for important intellectual content: ADO, BJS, MC, RM, GEU, DLH Declarations of interest GEU receives grant support from Novo Nordisk, Merck, Insulcloud, Dexcom, Abbott, AstraZeneca, and Bayer
You will also have access to the Medicare network